Search Prime Grants

U01HL134764

Cooperative Agreement

Overview

Grant Description
Integrated cellular and tissue engineering for ischemic heart disease.
Awardee
University Of Alabama At Birmingham
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
93.837 - Cardiovascular Diseases Research
Awarding / Funding Agency
National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]
Place of Performance
Alabama United States
Geographic Scope
State-Wide
Related Opportunity
NHLBI Progenitor Cell Translational Consortium (U01) (RFA-HL-16-021)
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/23 to 05/31/25 and the total obligations have increased 699% from $949,976 to $7,593,074.
University Of Alabama At Birmingham was awarded Integrated Cellular and Tissue Engineering for Ischemic Heart Disease Cooperative Agreement U01HL134764 worth $7,593,074 from National Heart Lung and Blood Institute in September 2016 with work to be completed primarily in Alabama United States. The grant has a duration of 8 years 8 months and was awarded through assistance program 93.837 Cardiovascular Diseases Research. The Cooperative Agreement was awarded through grant opportunity NHLBI Progenitor Cell Translational Consortium (U01).

Status
(Complete)

Last Modified 12/5/25

Period of Performance
9/15/16
Start Date
5/31/25
End Date
100% Complete

Funding Split
$7.6M
Federal Obligation
$0.0
Non-Federal Obligation
$7.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01HL134764

Subgrant Awards

Disclosed subgrants for U01HL134764

Transaction History

Modifications to U01HL134764

Additional Detail

Award ID FAIN
U01HL134764
SAI Number
U01HL134764-2704296123
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
YND4PLMC9AN7
Awardee CAGE
0DV74
Performance District
AL-90
Senators
Tommy Tuberville
Katie Britt

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) Health research and training Grants, subsidies, and contributions (41.0) $8,822,309 100%
Modified: 12/5/25